Lung Therapeutics Doses First Patient in Trial of LTI-01 for Empyema, Pleural Effusion
Lung Therapeutics has enrolled its first patient in a Phase 1 a/b clinical trial assessing LTI-01, a drug designed to treat pleural effusions, a severe complication of pneumonia. The study, taking place at ... Read more